Vanda Pharmaceuticals Inc. (VNDA): Price and Financial Metrics
Vanda Pharmaceuticals Inc. (VNDA)
Today's Latest Price: $11.67 USD
Updated Aug 14 12:00am
Add VNDA to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
VNDA Stock Summary
- VNDA's current price/earnings ratio is 5.6, which is higher than merely 5.87% of US stocks with positive earnings.
- The ratio of debt to operating expenses for Vanda Pharmaceuticals Inc is higher than it is for about just 8.62% of US stocks.
- VNDA's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of merely 10.71% of US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to Vanda Pharmaceuticals Inc are ICAD, AMSC, SSYS, DDD, and APDN.
- Visit VNDA's SEC page to see the company's official filings. To visit the company's web site, go to www.vandapharma.com.
VNDA Stock Price Chart Technical Analysis Charts
VNDA Price/Volume Stats
| Current price | $11.67 | 52-week high | $17.85 |
| Prev. close | $11.88 | 52-week low | $7.12 |
| Day low | $11.50 | Volume | 331,500 |
| Day high | $11.92 | Avg. volume | 693,480 |
| 50-day MA | $11.29 | Dividend yield | N/A |
| 200-day MA | $12.65 | Market Cap | 637.78M |
Vanda Pharmaceuticals Inc. (VNDA) Company Bio
Vanda Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders. The company was founded in 2002 and is based in Washington, the District of Columbia.
Loading social stream, please wait...